aTYR PHARMA INC Class of Warrant or Right, Outstanding
aTYR PHARMA INC (ATYR) had Class of Warrant or Right, Outstanding of 13.90 thousand shares as of 2020-12-31, per its 10-K filed 2021-03-24.
Discontinued › Notes
us-gaap:ClassOfWarrantOrRightOutstanding · last filed 2021-03-24
- 2020-12-31: Class of Warrant or Right, Outstanding 13.90K shares.
- 2019-12-31: Class of Warrant or Right, Outstanding 13.90K shares.
- 2018-12-31: Class of Warrant or Right, Outstanding 6.68M shares.
- 2017-12-31: Class of Warrant or Right, Outstanding 6.68M shares.
| Period end | Class of Warrant or Right, Outstanding |
|---|---|
| 2020-12-31 | 13.90K shares 10-K · filed 2021-03-24 |
| 2019-12-31 | 13.90K shares 10-K · filed 2020-03-26 |
| 2018-12-31 | 6.68M shares 10-K · filed 2019-03-26 |
| 2017-12-31 | 6.68M shares 10-K · filed 2018-03-20 |
| 2016-12-31 | 121.51K shares 10-K · filed 2017-03-16 |
| 2015-12-31 | 25.97K shares 10-K · filed 2016-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quince Therapeutics, Inc. (QNCX) | United States | $0.031B | |
| CEL SCI CORP (CVM) | United States | $0.030B | -0.81 |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B |